Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c

Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance